Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Gut Microbiota Market Growth in 2025?

Over the last few years, the gut microbiota market has seen quick expansion. The market size, which was at $0.55 billion in 2024, is projected to increase to $0.65 billion in 2025, representing a compound annual growth rate (CAGR) of 18.5%. Factors such as the identification of probiotics and prebiotics, growing instances of gastrointestinal disorders, a renewed interest in functional foods, increasing usage of antibiotics, and the surge in recognition of the gut-brain axis have contributed to the growth during the historic period.

What Is the Forecast for the Gut Microbiota Market Size Through 2029?

The market for gut microbiota is anticipated to experience swift expansion in the forthcoming years. The market value is projected to reach $1.27 billion in 2029, escalating at a compound annual growth rate (CAGR) of 18.2%. This projected growth during the forecast period can be credited to the growth of personalized nutrition, an increased interest in microbiome-based therapeutics, the popularity of fermented and functional foods, and support from regulatory bodies for prebiotics and probiotics. Key market trends during the forecast period are expected to include AI-enabled microbiome analysis, advancements in next-generation sequencing, gut microbiota editing using CRISPR, evolution of intelligent probiotic delivery systems, and wearable devices for gut health monitoring.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23411&type=smp

What are the Key Market Players in Gut Microbiota Market and How They’re Evolving?

Major companies operating in the gut microbiota market are Danone S.A., DuPont de Nemours Inc., International Flavors & Fragrances Inc., Seres Therapeutics, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., Lifeway Foods Inc., BioGaia AB, Probi AB, Seed Health, Enterome, Vedanta Biosciences Inc., Evolve BioSystems Inc., Winclove Probiotics B.V., Kallyope Inc., Sun Genomics Inc., Synlogic Inc., OpenBiome, Codex Labs Corp.

What Are the Primary Growth Drivers in the Gut Microbiota Market?

The rise in the need for personalized medicine is anticipated to stimulate the expansion of the gut microbiota market. Personalized medicine takes into consideration an individual’s genetical, environmental, and lifestyle parameters to cater to treatments that enhance their health and deliver better care. With the progression of genomics and biotechnology, more accurate genetic profiling has become possible – leading to the personalization of treatments; enhancing their efficacy and minimizing their side effects. Personalized medicine, in the case of gut microbiota, helps in customizing treatments as per the unique composition of an individual’s microbiome. This optimizes the health of their gut, and advances outcomes for disorders related to metabolism and digestion. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a nonprofit organization based in the US, stated that the U.S. Food and Drug Administration (FDA) gave approval to 26 new personalized medicines in 2023. This was a momentous rise in comparison to the 12, which had been approved in the previous year, 2022. Hence, the escalating demand for personalized medicine is fueling the growth of the gut microbiota market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=23411&type=smp

What Are the Leading Segments in the Global Gut Microbiota Industry?

The gut microbiota market covered in this report is segmented –

1) By Product: Prebiotics, Probiotics, Drugs, Supplements, Other Products

2) By Application: Digestive Health, Immune Health, Weight Management, Mental Health, Cardiovascular Health

3) By Distribution Channel: Pharmacies And Drugstores, Online Retail, Health Food Stores, Super markets And Hyper markets, Specialty Stores

4) By End-Users: Adults, Children, Elderly

Subsegments:

1) By Prebiotics: Fructooligosaccharides (Fos), Galactooligosaccharides (Gos), Inulin, Resistant Starch, Beta-Glucans, Arabinogalactans, Pectins

2) By Probiotics: Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, Bacillus, Escherichia

3) By Drugs: Antibiotics, Bacteriophage Therapy, Gut Microbiota Modulators, Immunomodulators, Antidiarrheal Agents, Laxatives

4) By Supplements: Synbiotics, Postbiotics, Enzyme Supplements, Vitamin D Supplements, Omega-3 Fatty Acids, Herbal Extracts

5) By Other Products: Functional Foods, Fermented Foods, Beverages, Gut Health Diagnostic Kits, Dietary Fiber Products

What Are the Key Market Trends in the Gut Microbiota Industry?

Major corporations in the gut microbiota market are honing in on innovative strategies, such as fecal microbiota taken orally, to treat numerous digestive diseases and disorders. This form of treatment involves ingesting a tablet or capsule filled with beneficial bacteria from the stool of a healthy donor to reestablish equilibrium in the gut microbiome. For example, in April 2023, Seres Therapeutics Inc., a microbiome therapeutics firm based in the US, was granted FDA approval for Vowst, the first orally taken fecal microbiota product made to thwart recurring Clostridioides difficile (C. difficile) infection (CDI) in those aged 18 and up. Vowst is slated for use following antibiotic treatment for recurring CDI. This approval signifies a notable progression in CDI treatment, offering a more user-friendly and readily available substitute to traditional fecal microbiota transplants, which are typically given via colonoscopy or enema. Its oral formulation is likely to enhance treatment compliance and increase the acceptance of microbiome-based therapies in the medical sector.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/gut-microbiota-global-market-report

What Is the Regional Outlook for the Gut Microbiota Market?

North America was the largest region in the gut microbiota market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gut microbiota market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23411

This Report Delivers Insight On:

1. How big is the gut microbiota market, and how is it changing globally?

2. Who are the major companies in the gut microbiota market, and how are they performing?

3. What are the key opportunities and risks in the gut microbiota market right now?

4. Which products or customer segments are growing the most in the gut microbiota market?

5. What factors are helping or slowing down the growth of the gut microbiota market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model